These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15302292

  • 1. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
    Barak V, Elchalal U, Edelstein M, Kalickman I, Lewin A, Abramov Y.
    Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y, Barak V, Nisman B, Schenker JG.
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-18 is high in the serum of IVF pregnancies with ovarian hyperstimulation syndrome.
    Gutman G, Soussan-Gutman L, Malcov M, Lessing JB, Amit A, Azem F.
    Am J Reprod Immunol; 2004 May; 51(5):381-4. PubMed ID: 15212675
    [Abstract] [Full Text] [Related]

  • 4. Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study.
    D'Angelo A, Davies R, Salah E, Nix BA, Amso NN.
    Fertil Steril; 2004 Feb; 81(2):332-6. PubMed ID: 14967369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [Abstract] [Full Text] [Related]

  • 7. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
    Ayustawati, Shibahara H, Hirano Y, Suzuki T, Takamizawa S, Suzuki M.
    Fertil Steril; 2004 Sep; 82(3):579-85. PubMed ID: 15374699
    [Abstract] [Full Text] [Related]

  • 8. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome.
    Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V.
    Hum Reprod; 1996 Jul; 11(7):1381-6. PubMed ID: 8671471
    [Abstract] [Full Text] [Related]

  • 9. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Abramov Y, Schenker JG, Lewin A, Kafka I, Jaffe H, Barak V.
    Fertil Steril; 2001 Jul; 76(1):51-7. PubMed ID: 11438319
    [Abstract] [Full Text] [Related]

  • 10. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A, Coccia ME, Fedi S, Gori AM, Cellai AP, Scarselli GF, Prisco D, Abbate R.
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R, Morris S.
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F, Peñarrubia J, Vidal E, Casals G, Vanrell JA, Balasch J.
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP, Hacker MR, Alper MM.
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [Abstract] [Full Text] [Related]

  • 17. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW, Maier DB, Nulsen JC, Benadiva CA.
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T.
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.